Deborah Lehrer
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Pathology and Forensic Medicine top 10%
- Cancer Mechanisms and Therapy
Papers in
- Oncology 10
- Colorectal Cancer Treatments and Studies 4
- Cancer Treatment and Pharmacology 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Co-authors
- Jonathan D. Schwartz (7 shared papers)John Mandeli (5 shared papers)Allyson J. Ocean (2 shared papers)E. Cohen (2 shared papers)Alec Goldenberg (2 shared papers)Madhu Mazumdar (1 shared paper)Paul J. Christos (1 shared paper)Alan Weinberg (1 shared paper)
- Journals
- Journal of Clinical Oncology (10 papers)Journal of Pharmacy and Pharmacology (2 papers)Clinical Cancer Research (1 paper)European Journal of Cancer (1 paper)Nature (1 paper)
- Partner nations
- United StatesNew ZealandCanada
In The Last Decade
Deborah Lehrer
20 papers receiving 690 citations
Peers
Comparison fields: 5 of 66
- Hepatology 337
- Pathology and Forensic Medicine 152
- Oncology 189
- Cancer Research 95
- Immunology 109
Countries citing papers authored by Deborah Lehrer
This map shows the geographic impact of Deborah Lehrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Lehrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Lehrer more than expected).
Fields of papers citing papers by Deborah Lehrer
This network shows the impact of papers produced by Deborah Lehrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Lehrer. The network helps show where Deborah Lehrer may publish in the future.
Co-authors
The 25 scholars most cited alongside Deborah Lehrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 380 | |
| 2 | 2018 | 100 | |
| 3 | 2006 | 38 | |
| 4 | 2005 | 24 | |
| 5 | 1993 | 22 | |
| 6 | 1963 | 19 | |
| 7 | Phase 1 study of intravenous rigosertib (ON 01910.Na), a novel benzyl styryl sulfone structure producing G2/M arrest and apoptosis, in adult patients with advanced cancer. | 2013 | 18 |
| 8 | 1966 | 17 | |
| 9 | 2005 | 17 | |
| 10 | 2004 | 16 | |
| 11 | 2006 | 11 | |
| 12 | 1965 | 10 | |
| 13 | 2010 | 10 | |
| 14 | 2002 | 9 | |
| 15 | 1992 | 8 | |
| 16 | 2011 | 4 | |
| 17 | 1962 | 2 | |
| 18 | 2008 | 2 | |
| 19 | 2004 | 2 | |
| 20 | 2014 | 1 |
About Deborah Lehrer
Deborah Lehrer is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research, having authored 21 papers that have together received 710 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (3 papers), Cancer Genomics and Diagnostics (2 papers), Renal cell carcinoma treatment (2 papers), Multiple and Secondary Primary Cancers (2 papers), Ion channel regulation and function (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Hepatology (337 citations), Pathology and Forensic Medicine (152 citations), Oncology (189 citations), Cancer Research (95 citations) and Immunology (109 citations). Deborah Lehrer has collaborated with scholars based in United States, New Zealand and Canada. Frequent co-authors include Jonathan D. Schwartz, John Mandeli, Allyson J. Ocean, E. Cohen, Alec Goldenberg, Madhu Mazumdar, Paul J. Christos, Alan Weinberg, Jennifer J. Knox and E Popa. Their work appears in journals such as Journal of Clinical Oncology, Journal of Pharmacy and Pharmacology, Clinical Cancer Research, European Journal of Cancer and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.